Technical Analysis for BIEI - Premier Biomedical

Grade Last Price % Change Price Change
grade D 0.0086 -1.15% -0.0001
BIEI closed down 1.15 percent on Tuesday, August 20, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical BIEI trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -1.15%
Calm After Storm Range Contraction -1.15%
Outside Day Range Expansion -1.15%

Older signals for BIEI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically focusing the treatment of Cancer, Multiple Sclerosis (MS), Neuropathic Pain, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Fibromyalgia, Traumatic Brain Injury (TBI), Alzheimer's disease (AD), and Blood Sepsis and Viremia. The Company intends to develop its Sequential-Dialysis Technique, to target Cancer, Alzheimer's disease, ALS, Blood Sepsis, Leukemia and other life-threatening cancers. The Sequential-Dialysis Technique is a methodology for the removal of those molecules, which are harmful and responsible for causing diseases. Its Sequential-Dialysis Technique method removes those excitatory neural transmitters that cause the death of those cells. It also intends to develop Feldetrex, a candidate drug, for the treatment of MS, Fibromyalgia and TBI. Feldetrex utilizes a low dosage of Naltrexone to increase endogenous enkephalins10.
Medicine RTT Medical Specialties Cancer Pain Diseases Treatment Of Cancer Cancers Dialysis Multiple Sclerosis Alzheimer's Disease Leukemia Fibromyalgia Sepsis Amyotrophic Lateral Sclerosis Traumatic Brain Injury Ms Als Blood Sepsis
Is BIEI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.56
52 Week Low 0.005
Average Volume 1,167,193
200-Day Moving Average 0.0447
50-Day Moving Average 0.0114
20-Day Moving Average 0.0114
10-Day Moving Average 0.0132
Average True Range 0.0054
ADX 29.67
+DI 28.6093
-DI 17.0861
Chandelier Exit (Long, 3 ATRs ) 0.0178
Chandelier Exit (Short, 3 ATRs ) 0.0212
Upper Bollinger Band 0.0245
Lower Bollinger Band -0.0017
Percent B (%b) 0.39
BandWidth 229.824561
MACD Line -0.0002
MACD Signal Line 0.0003
MACD Histogram -0.0005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0124
Resistance 3 (R3) 0.0123 0.0110 0.0117
Resistance 2 (R2) 0.0110 0.0100 0.0110 0.0115
Resistance 1 (R1) 0.0098 0.0095 0.0092 0.0099 0.0113
Pivot Point 0.0085 0.0085 0.0082 0.0085 0.0085
Support 1 (S1) 0.0073 0.0075 0.0067 0.0074 0.0059
Support 2 (S2) 0.0060 0.0070 0.0060 0.0057
Support 3 (S3) 0.0048 0.0060 0.0055
Support 4 (S4) 0.0049